Onvansertib (NMS-P937)
Product Specifications
CAS Number
1034616-18-6
Synonyms
PCM-075, NMS1286937
Target
PLK
Applications
Cell Cycle
Smiles
CN1CCN (CC1) C2=CC (=C (C=C2) OC (F) (F) F) NC3=NC=C4CCC5=C (C4=N3) N (N=C5C (=O) N) CCO
Molecular Formula
C24H27F3N8O3
Additionnal Information
Onvansertib (NMS-P937, PCM-075, NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Onvansertib (NMS-P937) potently causes a mitotic cell-cycle arrest followed by apoptosis in cancer cell lines and inhibits tumor growth. Phase 1.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
519120 96 Tests
ALAD (Aminolevulinate Delta Dehydratase) BioAssayTM Elisa kit (Mouse) discontinued
Sign In for Pricing
View Details 
orb3087936 200 µL
Fission yeast BRL1 Rabbit Polyclonal Antibody (Fluoro647)
Sign In for Pricing
View Details MBS6407367-01 0.1 mL
ASNA1 (ATPase ASNA1, Arsenical Pump-driving ATPase, GET3, ARSA1, TRC40, ARSA-I, ASNA-I, hASNA-I) (AP)
Sign In for Pricing
View Details MBS6407367-02 5x 0.1 mL
ASNA1 (ATPase ASNA1, Arsenical Pump-driving ATPase, GET3, ARSA1, TRC40, ARSA-I, ASNA-I, hASNA-I) (AP)
Sign In for Pricing
View Details MBS355717-01 1 g
Monosialotetrahexosylganglioside Sodium Salt (GM1)
Sign In for Pricing
View Details